The Swiss Tropical and Public Health Institute (Swiss TPH) is a world-leading institute in global health with a particular focus on low- and middle-income countries. Associated with the University of Basel, Swiss TPH combines research, education and services at local, national and international levels.
With around 1,000 professionals and students from 96 nations, Swiss TPH is united by a shared commitment to improving health and well-being worldwide. Its interdisciplinary work covers the entire range of global health challenges – from climate change and infectious diseases to non-communicable diseases and health system strengthening. Swiss TPH bridges the gap between scientific discovery and practical application, ensuring that innovative health solutions translate into real-world impact. This translational approach – from innovation and validation to application – enables the institute to deliver novel diagnostics, drugs and vaccines directly to those who need them most: individuals, communities and decision-makers. Active in more than 126 countries, Swiss TPH advance global health through innovation, partnerships and practical implementation.
Swiss TPH supports the clinical trial on female genital schistosomiasis (FGS) by providing expertise in clinical research coordination, data management, and capacity strengthening. Through close collaboration with the local and international teams, we help ensure the trial’s scientific rigor, ethical integrity, and operational efficiency. Our involvement contributes to generating much-needed evidence for improved diagnosis and treatment of FGS, ultimately aiming to enhance the health and well-being of women and girls affected by this neglected tropical disease.
“I am committed to contributing to the development of a treatment for the morbidity of FGS and to improving the lives of girls and women in Africa.”
“This work offers the opportunity to contribute to improving the health of women and girls affected by female genital schistosomiasis, whose needs have long been neglected.”
